Kafadar Mehmet Tolga, Bahadır Mehmet Veysi, Girgin Sadullah
Department of General Surgery, Dicle University School of Medicine, Diyarbakır, Turkey.
Breast Care (Basel). 2021 Aug;16(4):402-407. doi: 10.1159/000513879. Epub 2021 Jan 22.
Idiopathic granulomatous mastitis (IGM) is a rare, recurrent and progressive breast disease with an unknown etiology. Patients with IGM will probably face stressful, time-consuming treatment procedures with side effects due to medications. There are different treatment modalities in clinical use including medical and surgical interventions.
The aim of this study was to present the results of using the combination therapy of low-dose methotrexate (MTX) and steroid in IGM.
Seventeen patients diagnosed with IGM and treated with MTX were included into the study. Low-dose MTX at 5 mg/week and 8 mg/day prednisone were given for 2-3 months.
After 2-3 months of treatment, 10 patients exhibited (58.5%) complete, 3 patients (17.6%) partial recovery, and no response to the treatment process was observed in 4 patients (23.5%). No side effects of MTX and recurrent events were noted in any of the patients.
Low-dose MTX and prednisone treatment for IGM patients, who did not respond to steroids alone, should be considered as an alternative treatment method instead of surgical intervention.
特发性肉芽肿性乳腺炎(IGM)是一种罕见的、复发性且进行性的乳腺疾病,病因不明。IGM患者可能会面临压力大、耗时且因药物产生副作用的治疗过程。临床使用的治疗方式有多种,包括药物和手术干预。
本研究的目的是呈现低剂量甲氨蝶呤(MTX)与类固醇联合治疗IGM的结果。
17例诊断为IGM并接受MTX治疗的患者纳入本研究。给予每周5mg的低剂量MTX和每日8mg的泼尼松,治疗2 - 3个月。
治疗2 - 3个月后,10例患者(58.5%)完全康复,3例患者(17.6%)部分康复,4例患者(23.5%)对治疗过程无反应。所有患者均未出现MTX的副作用及复发事件。
对于单独使用类固醇无反应的IGM患者,低剂量MTX和泼尼松治疗应被视为一种替代治疗方法,而非手术干预。